BNO 5.26% 20.0¢ bionomics limited

I am unconvinced about the residual value in the assets.They...

  1. 707 Posts.
    lightbulb Created with Sketch. 78
    I am unconvinced about the residual value in the assets.

    They have had such limited commercial interest in any of the "pipeline" drugs that I just question whether they actually have any worth.

    I guess that they could prove me wrong, but the cash will likely run out before they can get a deal.

    Merck is the only one with and interest and my bet is that they will buy all of the assets out of receivership for a song.

    They do not need to bid for the company nor pay a premium in the absence of any other buyers.

    I guess we will just have to wait and see.........
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.